Evidence map›Paper›PMID 38184533›Full record

Observational studyBMC infectious diseases2024

Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.

Farzin Sadeghi, Mehrdad Halaji, Hoda Shirafkan, Abazar Pournajaf, Hossein Ghorbani, Sara Babazadeh, Nafiseh Ezami, Kobra Fallhpour, Fatemeh Fakhraie, Shahrbano Gorjinejad and 25 more

Open access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Hospitalization costs of patients with severe acute respiratory infections due to COVID-19 in a public teaching hospital: a micro-costing approach.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 3 institutions in 2 countries.

Farzin Sadeghi *Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Mehrdad Halaji *Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Hoda ShirafkanSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Science, Babol, Iran.
Abazar PournajafInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Hossein GhorbaniClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Sara BabazadehClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Nafiseh EzamiPart of Medical Records, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Kobra FallhpourPart of Infectious Control, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran.
Fatemeh FakhraiePart of Infectious Control, Shahid Yahyanejad Hospital, Babol University of Medical Sciences, Babol, Iran.
Shahrbano GorjinejadPart of Infectious Control, Amirkola Hospital, Babol University of Medical Sciences, Babol, Iran.
Saghar Saber AmoliDepartment of Medical Microbiology and Biotechnology Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
Fatemeh Hejazi AmiriDepartment of Medical Microbiology and Biotechnology Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
Mahnaz BaghershiroodiCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Zahra AhmadniaClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Maryam SalehiClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Mehdi TouraniCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Jalal JafarzadehClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Farzane Shanehbandpour TabariCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Seyed Raheleh AhmadianInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Rouzbeh Mohammadi AbandansariClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Farzaneh JafarianClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Samaneh RouhiClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Arezoo ZabihollahiClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Sarina MostafanezhadClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Fatemeh SaeediDepartment of Pathology, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Arefeh EbrahimianDepartment of Medical Microbiology and Biotechnology Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
Zeinab DeldarDepartment of Medical Microbiology and Biotechnology Faculty of Medicine Guilan, University of Medical Sciences, City, Ondo, Nigeria.
Mahmoud Sadeghi Haddad ZavarehInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Masoumeh BayaniInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Mana Bazi BrounInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Moein ShirzadInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Siamak SabbaghiClinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Mohsen MohammadiNon-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Rabeae RahmaniMSc. in Cellular and Molecular Biology, Education of Amol Teacher, Amol, Iran.
Yousef YahyapourInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. uyahyapoor@yahoo.com.
Babol University of Medical Sciences · IRAmol University of Special Modern Technologies · IROndo State University of Science and Technology · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of the present study was to compare the epidemiological patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infections, hospitalizations, deaths, and duration of hospitalization during the fourth, fifth and sixth epidemic waves of coronavirus disease 2019 (COVID-19) in Iran.

methodsA multicenter retrospective observational study was conducted on hospitalized patients in four hospitals in the Babol district of northern Iran. The study periods were during the fourth, fifth, and sixth waves of the epidemic in Iran, (March 2021 to March 2022). A total of 13,312 patients with suspected COVID-19 were included. Patient demographics, medical history, length of hospital stay, and clinical outcomes were obtained from the hospital information system. Data on the cycle threshold (Ct) and SARS-CoV2 variant were collected for SARS-CoV2-positive cases.

resultsThe highest number of hospitalized patients was reported during the fifth (Delta) wave (5231; 39.3%), while the lowest number of hospitalized patients was reported during the sixth (Omicron) wave (2143; 16.1%). In total, 6459 (48.5%) out of 13,312 hospitalized patients with suspected COVID-19 had a positive rRT-PCR result. The fifth (Delta) wave had the highest number of SARS-CoV2 rRT-PCR-positive hospitalized patients (3573, 55.3%), while the sixth (Omicron) wave had the lowest number (835, 12.9%). Moreover, 238 (3.7%) patients with laboratory-confirmed COVID-19 died. The hospital mortality rate was 6.8% in the fourth (Alpha) wave, which reduced to 2.7 and 3.5% in the fifth (Delta) and sixth (Omicron) waves, respectively (p < 0.001).

conclusionsThis is the most comprehensive study evaluating the epidemiologic characteristics of laboratory-confirmed SARS-CoV2 cases in Iran during the Alpha, Delta, and Omicron waves. The highest number of SARS-CoV2-positive hospitalized patients was in the fifth wave of COVID-19 (dominance of the Delta variant), while the sixth wave (dominance of the Omicron variant) had the lowest number. Comorbidities were similar, and cardiovascular disease, diabetes, kidney disease, and hypertension were the main risk factors in all waves.

Indexed as

COVID-19SARS-CoV-2HospitalizationHospitalsHumansRNA, ViralRNA, ViralAlpha variantCOVID-19DeathDelta variantHospitalizationOmicron variantSARS-CoV-2

Identifiers

PMID38184533
PMCPMC10771668
OpenAlexW4390636770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.